 |
|
Novel treatments for inflammatory bowel disease
Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
Korean J Intern Med. 2018;33(1):20-27. Published online 2017 Dec 11 DOI: https://doi.org/10.3904/kjim.2017.393
|
|
Citations to this article as recorded by
 Tiron ameliorates acetic acid-induced colitis in rats: Role of TGF-β/EGFR/PI3K/NF-κB signaling pathway
Raghda N. El Mahdy, Manar A. Nader, Manar G. Helal, Sally E. Abu-Risha, Marwa E. Abdelmageed
International Immunopharmacology.2024; 128: 111587. CrossRef Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn’s disease
Bo-Jun Ke, Saeed Abdurahiman, Francesca Biscu, Gaia Zanella, Gabriele Dragoni, Sneha Santhosh, Veronica De Simone, Anissa Zouzaf, Lies van Baarle, Michelle Stakenborg, Veronika Bosáková, Yentl Van Rymenant, Emile Verhulst, Sare Verstockt, Elliott Klein, G
Journal of Clinical Investigation.2024;[Epub] CrossRef Immunomodulatory effect of Dicrocoelium dendriticum ova on DSS-induced experimental colitis in C57BL/6 mouse
Leila Mighani, Malihe Eilakinezhad, Seyed-Alireza Esmaeili, Majid Khazaei, Moein Eskandari, Seyedeh Elnaz Nazari, Mojtaba Mousavi Bazaz, Khatereh kharazmi, Elham Moghaddas, Mehdi Zarean
Scientific Reports.2024;[Epub] CrossRef Ileo-Anal Pouch Anastomosis and New Remedial Approaches for Ulcerative Colitis: A Review Article
Abhijeet Jankar, Tripti Shrivastava
Cureus.2023;[Epub] CrossRef Eicosapentaenoic acid mitigates ulcerative colitis-induced by acetic acid through modulation of NF-κB and TGF-β/ EGFR signaling pathways
Raghda N. El Mahdy, Manar A. Nader, Manar G. Helal, Sally E. Abu-Risha, Marwa E. Abdelmageed
Life Sciences.2023; 327: 121820. CrossRef APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
Lauren Sahakian, Ainsley M. Robinson, Linda Sahakian, Rhian Stavely, Mark R. Kelley, Kulmira Nurgali
Biomolecules.2023; 13(11): 1569. CrossRef The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease
Maiss Reghefaoui, Tariladei S Peresuodei, Michell S Saavedra Palacios, Abhishek Gill, Chijioke Orji, Tiba Reghefaoui, Jihan Mostafa
Cureus.2023;[Epub] CrossRef Electrical carotid sinus nerve stimulation attenuates experimental colitis induced by acetic acid in rats
Jefferson Ícaro Soares, Thaís Marques da Silva, Jaci Airton Castania, Ulisses Ávila Reis, Luiz Felipe Moreira Roque, Adriana Barbosa Ribeiro, Helio Cesar Salgado, Aline Barbosa Ribeiro
Life Sciences.2023; 335: 122281. CrossRef Protective Effect of Colocasia esculenta on TNBS Induced Ulcerative Colitis in Mice
Srikanta Chandra, Tathagata Roy, Preeta Bose, Somsubhra Ghosh, Susanta Paul, Victor roychowdhury, Anannya Bose, Ankita Acharya
Research Journal of Pharmacy and Technology.2022; : 385. CrossRef Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
Juliana Setyawan, Fan Mu, Miriam L. Zichlin, Emma Billmyer, Nathaniel Downes, Hongbo Yang, Nassir Azimi, Vibeke Strand, Andres Yarur
Advances in Therapy.2022; 39(1): 738. CrossRef Preventive empagliflozin activity on acute acetic acid-induced ulcerative colitis in rats via modulation of SIRT-1/PI3K/AKT pathway and improving colon barrier
Marwa S. Zaghloul, Mahmoud Elshal, Marwa E. Abdelmageed
Environmental Toxicology and Pharmacology.2022; 91: 103833. CrossRef Helicobacter pylori infection in patients with inflammatory bowel diseases: a single-centre, prospective, observational study in Egypt
Ekram W. Abd El-Wahab, Ebtessam I. Youssef, Ehab Hassouna
BMJ Open.2022; 12(5): e057214. CrossRef IBD therapeutics: what is in the pipeline?
Alexandros Toskas, Ayesha Akbar
Frontline Gastroenterology.2022; 13(e1): e35. CrossRef Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Jung Won Lee, Chang Soo Eun
The Korean Journal of Internal Medicine.2022; 37(5): 885. CrossRef Vaccination strategies for Korean patients with inflammatory bowel disease
Yoo Jin Lee, Eun Soo Kim
The Korean Journal of Internal Medicine.2022; 37(5): 920. CrossRef Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
Soo-Young Na, You Sun Kim
The Korean Journal of Internal Medicine.2022; 37(5): 906. CrossRef Therapeutic Efficacy of Novel HDAC Inhibitors SPA3052 and SPA3074 against Intestinal Inflammation in a Murine Model of Colitis
Ji-In Yoon, Hyewon Cho, Raok Jeon, Mi-Kyung Sung
Pharmaceuticals.2022; 15(12): 1515. CrossRef Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium
Shruti Ahlawat, Pramod Kumar, Hari Mohan, Sandeep Goyal, Krishna Kant Sharma
Critical Reviews in Microbiology.2021; 47(2): 254. CrossRef Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activation
Rezvan Moallemian, Ashfaq Ur. Rehman, Na Zhao, Huan Wang, Haifeng Chen, Gang Lin, Xiaojing Ma, Jing Yu
Biochemical Pharmacology.2020; 177: 113964. CrossRef Experimental Evaluation of the Impact of Gadolinium Orthovanadate GdVO4:Eu3+ Nanoparticles on the Carrageenan-Induced Intestinal Inflammation
Anton S. Tkachenko, Galina I. Gubina-Vakulyck, Vladimir K. Klochkov, Nataliya S. Kavok, Anatolii I. Onishchenko, Tatyana V. Gorbach, Oksana A. Nakonechna
Acta Medica (Hradec Kralove, Czech Republic).2020; 63(1): 18. CrossRef In vivo Imaging Technologies to Monitor the Immune System
Claire E. McCarthy, Jordan M. White, Nerissa T. Viola, Heather M. Gibson
Frontiers in Immunology.2020;[Epub] CrossRef Challenges and opportunities for IBD drug development: from early stage to regulatory approval
Silvio Danese, Elmer Schabel, Mark Andrew Ainsworth, Laurent Peyrin-Biroulet
Gut.2020; 69(7): 1157. CrossRef Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways
Xiaobo Tang, Gengzhen Huang, Tao Zhang, Shiqing Li
Bioscience, Biotechnology, and Biochemistry.2020; 84(9): 1903. CrossRef High‐dimensional single‐cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitis
Sebastian Fuchs, Nadia Sawas, Nicolas Staedler, David A. Schubert, Annalisa D'Andrea, Robert Zeiser, Luca Piali, Petr Hruz, Andreas P. Frei
European Journal of Immunology.2019; 49(3): 462. CrossRef Zeaxanthin exerts protective effects on acetic acid-induced colitis in rats via modulation of pro-inflammatory cytokines and oxidative stress
Gehan El-Akabawy, Neveen M. El-Sherif
Biomedicine & Pharmacotherapy.2019; 111: 841. CrossRef Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
Caifang Gao, Lijuan Liu, Yangyang Zhou, Zhaoxiang Bian, Shengpeng Wang, Yitao Wang
Chinese Medicine.2019;[Epub] CrossRef Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer—a Critical Review
Adrian Szczepaniak, Jakub Fichna
Biomolecules.2019; 9(9): 398. CrossRef Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East
Ala I Sharara, Samir Al Awadhi, Othman Alharbi, Hisham Al Dhahab, Mohamed Mounir, Leonardo Salese, Ena Singh, Nancy Sunna, Nadine Tarcha, Mahmoud Mosli
Expert Review of Gastroenterology & Hepatology.2018; 12(9): 883. CrossRef Impact of Modern Drug Therapy on Surgery: Ulcerative Colitis
Florian Kuehn, Richard A. Hodin
Visceral Medicine.2018; 34(6): 426. CrossRef The Emerging Treatment Landscape of Inflammatory Bowel Disease: Role of Innovator Biologics and Biosimilars
Sam Reed
EMJ Gastroenterology.2018; : 50. CrossRef
|